Pharmacology · chapter 11 · Drugs to Treat Parkinson’s Disease and Multiple Sclerosis
Drugs Used in the Treatment of Multiple Sclerosis
The 14 things this section of the textbook says that you are most likely to be asked about — quoted word for word, not retold. Then 6 practice questions with the reasoning.
Key points
Start interferons early
They have antiviral, antiproliferative, and immunomodulatory actions and should be used early in the disease because they have been shown to modify disease progression and reduce relapse rates.
Flu-like symptoms with interferons
Flu-like symptoms on treatment days are common when first started. Symptoms experienced are fever, chills, myalgia, malaise, and sweating. These usually diminish over time.
Interferons and the liver
Interferon beta can injure the liver by causing an asymptomatic increase in circulating liver enzymes. Liver function tests must be monitored routinely.
Live vaccines and immunosuppression
Live vaccines should be avoided due to increased risk of vaccine-related infections. If needed, clients should receive them at least 4–6 weeks before starting therapy, especially the varicella-zoster virus (VZV) vaccine if one did not have chickenpox.
Glatiramer postinjection reaction
It can cause postinjection reactions including flushing, urticaria, chest tightness, palpitations, or dyspnea. These should last only a few minutes and subside spontaneously.
Teriflunomide and ALT
Teriflunomide is very hepatoxic throughout therapy. If the alanine aminotransferase (ALT) amount is three times the upper normal limit on two consecutive tests, the drug must be immediately stopped, and an accelerated elimination procedure will begin.
Teriflunomide in pregnancy
In addition, this drug is highly teratogenic, and a negative pregnancy test must be obtained before therapy.
Screen for latent TB
Clients should be screened for latent tuberculosis (TB) before beginning therapy with immunomodulators because they have been found to activate latent TB, causing an active TB infection to develop.
Teriflunomide with warfarin
Teriflunomide can decrease the peak international normalized ratio (INR) by 25% in clients taking warfarin. Close monitoring of the INR is warranted to evaluate for warfarin dose adjustments to maintain therapeutic levels.
S1P modulators slow the heart
Initiation of S1P drug therapy results in a decrease in heart rate, for which monitoring is recommended. The nurse should administer the first dose in a setting in which resources to appropriately manage symptomatic bradycardia are available.
Macular edema with S1P modulators
Fundoscopic examinations are essential before and 3–4 months after the treatment has been started. They are also performed again whenever a client reports visual disturbances.
Stopping baclofen too quickly
If the oral version of baclofen is stopped too quickly, this can cause the development of psychoses, visual hallucinations, and seizures. The drug should be tapered off over a 1- to 2-week period.
Dantrolene and the liver
Dose-related hepatotoxicity is the most serious adverse effect. Baseline liver enzymes should be obtained and monitored periodically throughout treatment.
Stop GABA analogs at angioedema
The drug should immediately be discontinued at the first sign of angioedema or other hypersensitivity reaction, such as hives, rash, wheezing, or dyspnea.
Terms to know
- Interferons
- Interferons are proteins that are released in response to pathogens.
- Monoclonal antibodies
- Monoclonal antibodies are derived from a single B-cell source.
- lipoatrophy
- Injection sites should be rotated to prevent lipoatrophy (localized loss of fat tissue).
- hypertonia
- Spasticity results in the excessive stimulation of muscles (hypertonia) in opposing muscle groups at the same time.
Practice questions
Stuck on select-all-that-apply? How to take them one option at a time.
The graded version needs JavaScript. Every question is below anyway, with the answer and why.
Every question here, with the answer
A client with relapsing MS starts interferon beta-1b and reports fever, chills and muscle aches on injection days. What should the nurse recommend?
- Take an analgesic-antipyretic on the days of treatment.
- Double the fluid intake and skip the next dose.
- Inject the drug into a different muscle group.
- Stop the drug until the symptoms go away.
Answer: Take an analgesic-antipyretic on the days of treatment.
Flu-like symptoms are common when interferons are started and are reduced by taking an analgesic-antipyretic on treatment days. Stopping or skipping doses is not the teaching, and interferon beta-1b is given subcutaneously, not into a muscle.
A client taking teriflunomide has an ALT three times the upper normal limit on two consecutive tests. What does the nurse anticipate?
- The drug will be continued with weekly ALT checks.
- Warfarin will be added to protect the liver.
- The dose will be reduced by half.
- The drug will be stopped and an accelerated elimination procedure begun.
Answer: The drug will be stopped and an accelerated elimination procedure begun.
Teriflunomide is very hepatotoxic; with ALT three times the upper limit on two consecutive tests, it must be stopped immediately and accelerated elimination (cholestyramine or activated charcoal) begins. Lowering the dose or continuing is not what the section describes, and warfarin does not protect the liver.
A nurse is preparing to start teriflunomide for a client of reproductive age. Which actions belong before therapy begins? Select all that apply.
- Stop the client's oral contraceptive.
- Perform a tuberculin skin test or IGRA.
- Obtain baseline ALT, AST and bilirubin.
- Give a live varicella vaccine on the first day of therapy.
- Obtain a pregnancy test.
Answer: Perform a tuberculin skin test or IGRA., Obtain baseline ALT, AST and bilirubin., Obtain a pregnancy test.
Teriflunomide is highly teratogenic, can activate latent TB, and is hepatotoxic, so a pregnancy test, TB screening and baseline liver tests come first. Live vaccines should be avoided during therapy, and because the drug can reduce oral contraceptive effectiveness, a backup barrier method is added rather than stopping contraception.
A client is receiving the first dose of siponimod in an outpatient clinic. What monitoring does the nurse carry out?
- Hourly heart rate and blood pressure for 6 hours.
- Pulse oximetry for 15 minutes only.
- Temperature once before discharge.
- Blood glucose every 30 minutes for 2 hours.
Answer: Hourly heart rate and blood pressure for 6 hours.
Starting an S1P receptor modulator lowers the heart rate, so all clients are monitored for 6 hours after the first dose with hourly heart rate and blood pressure. The other options do not watch for bradycardia over the required period.
A client with MS spasticity is taking oral baclofen. Which statements by the client show correct understanding? Select all that apply.
- "I will not drive until I know how the drug affects me."
- "I will not stop this drug suddenly."
- "I can drink alcohol because it relaxes my muscles too."
- "If I feel better, I can stop it on my own right away."
- "I will get up slowly from bed."
Answer: "I will not drive until I know how the drug affects me.", "I will not stop this drug suddenly.", "I will get up slowly from bed."
Baclofen must be tapered because abrupt withdrawal can cause psychoses, hallucinations and seizures; it can cause orthostatic hypotension and CNS depression, so the client rises slowly and avoids driving until effects are known. Alcohol adds CNS depression, and stopping abruptly is dangerous.
A client taking pregabalin develops swelling of the lips and tongue. What is the priority action?
- Taper the drug over one week.
- Give the next dose with an antihistamine.
- Document it as expected weight gain.
- Discontinue the drug immediately.
Answer: Discontinue the drug immediately.
Pregabalin must be stopped immediately at the first sign of angioedema, such as swelling of the face, tongue or lips. Tapering applies to planned discontinuation, and swelling of the lips and tongue is not weight gain.
Where every quote comes from
Section 11.4 Drugs Used in the Treatment of Multiple Sclerosis of Pharmacology for Nurses by Tina Barbour-Taylor, Leah Mueller (Sabato), Donna Paris, Dorie Weaver, OpenStax, 2024. Read the whole section free at openstax.org.
The textbook is licensed under CC BY-NC-SA 4.0. This page quotes it word for word and adds the headings, the order and the practice questions; references to the book's figures and stray spaces left by its formatting are removed. The page is shared under the same licence. Nothing here is sold.